January 27, 2009 - Mardil Inc., a cardiac device company with novel technology for treating mitral valve regurgitation, has successfully advanced its device to first-in-human testing, the company announced yesterday.

January 27, 2009 - According to research findings from Interventional Cardiologist Paul A. Gurbel, M.D., director of the Sinai Center for Thrombosis Research based at Sinai Hospital of Baltimore, platelet aggregation or "stickiness" may be the single most important risk factor in patients treated with coronary stents.

January 26, 2009 - CeloNova BioSciences Inc. recently received FDA 510(k) marketing clearance for Embozene Color-Advanced Microspheres, which are indicated for the treatment of hypervascularized tumors (tumors with a large number of blood vessels in many locations) and arteriovenous malformations (defects in the circulatory system).

January 26, 2009 - Cardiac Dimensions Inc. today said it achieved the implant target for the TITAN (TIghten The Annulus Now) safety study during the fourth quarter of 2008, which uses the CARILLON Mitral Contour System for percutaneous treatment of functional mitral regurgitation (FMR).

January 26, 2009 - Vascular Solutions Inc. recently launched its D-Stat Dry Wrap hemostatic bandage, a pre-cut version of its D-Stat Dry hemostat, designed specifically for the control of bleeding around indwelling lines.

January 26, 2009 - Edwards Lifesciences Corp. today launched the Carpentier-Edwards Physio II mitral valve repair ring at the 45th annual meeting of the Society of Thoracic Surgeons (STS) in San Francisco.

The new therapy represents the next generation of the Carpentier-Edwards Physio ring heart valve repair device.

January 23, 2009 - Isotechnika Inc. said yesterday that partner Atrium Medical Corp. has completed patient enrollment for their CONFIRM 1, First-in-Man (FIM) drug-coated coronary stent clinical trial evaluating Atrium's CINATRA voclosporin-coated coronary stent system.

January 19, 2009 – Researchers used magnetic resonance imaging (MRI) to show for the first time bleeding inside the heart after people have suffered a heart attack, a study published in the journal Radiology revealed.

January 23, 2009 - ATS Medical Inc. (ATS) is sponsoring "Frontiers in Cryoablation," a symposium designed to provide a unique forum for sharing experiences among physician attendees, to be held during the 45th Annual Meeting of the Society of Thoracic Surgeons (STS) Jan. 24-28, 2009 in San Francisco.

ATS Medical's Cryoablation Scientific Advisory Board members will lead the open discussion in a question and answer format. The symposium will be held on Sunday, Jan. 25th at 7:00 pm at the Marriott San Francisco.

January 22, 2009 – McKesson won a contract with the Baptist Healthcare System for the management of its physician revenue cycle designed to help affiliated physician staff address operational and revenue challenges.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now